Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
Prosopagnosia01:24

Prosopagnosia

162
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
162
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

186
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
186
Language Development01:22

Language Development

360
Children master language quickly and with relative ease, supported by both biological predisposition and reinforcement. B. F. Skinner (1957) proposed that language is learned through reinforcement, while Noam Chomsky (1965) argued that language acquisition mechanisms are biologically determined.
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
360
Long-term Potentiation01:35

Long-term Potentiation

55.2K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
55.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aspergillus-Infiltrated Optic Nerve Sheath Meningioma in Immunocompetent Host Mimicking Optic Neuritis.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same author

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial.

Journal of Alzheimer's disease : JAD·2026
Same author

Reviewer Comment on Pejhan et al. "Clinical relevance, and prognostic significance of isolated angiitis of the vasa vasorum in temporal artery biopsies".

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Peripheral microRNA signature in genetic frontotemporal dementia-findings from the GENFI initiative.

GeroScience·2026
Same author

Genetic and Hormonal Contributions to Psychosis Symptoms in Alzheimer's Disease: A Sex-Stratified Analysis.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same author

A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.

Nature genetics·2026
Same journal

A World Appears: A Journey into Consciousness: Pollan M. 2026. New York: Penguin Press. 280 pages. List price: $23.09.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2026
Same journal

Parallel Distributed Processing and Other Computational Models: Strengths, Weaknesses, and Possibilities.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2026
Same journal

Serum SIRT3 Levels and Their Relationship With Alzheimer Disease Pathological Markers in Individuals With Mild Cognitive Impairment.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2026
Same journal

Not Just for Adults: Transient Global Amnesia is Rare-But Possible-in Children.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2026
Same journal

Mysteries of the Social Brain: Understanding Human Behavior Through Science: Miller BL, Sturm V. New York: Routledge. 2024. 146 pages. List price $28.99.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2026
Same journal

Emotion Perception in Behavioral Variant Frontotemporal Dementia and Alzheimer Disease: The Parahippocampal Conundrum.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2026
See all related articles

Related Experiment Video

Updated: Jun 30, 2025

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
13:12

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping

Published on: August 12, 2019

45.4K

Progress in Primary Progressive Aphasia: A Review.

Andrew Kertesz1, Elizabeth Finger1, David G Munoz2

  • 1Department of Clinical Neurosciences, Western University Schulich School of Medicine & Dentistry, London, Ontario, Canada.

Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology
|March 18, 2024
PubMed
Summary
This summary is machine-generated.

Primary progressive aphasia (PPA) is reviewed, covering its definition, classification, and epidemiology. Advances in neuroanatomy, pathology, genetics, biomarkers, and treatments are discussed, alongside PPA

More Related Videos

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia
10:15

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

Published on: July 2, 2013

17.8K
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

34.8K

Related Experiment Videos

Last Updated: Jun 30, 2025

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
13:12

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping

Published on: August 12, 2019

45.4K
Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia
10:15

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

Published on: July 2, 2013

17.8K
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

34.8K

Area of Science:

  • Neurology
  • Linguistics
  • Genetics

Background:

  • Primary progressive aphasia (PPA) is a neurodegenerative disorder affecting language.
  • Understanding PPA's classification, epidemiology, and clinical taxonomy is crucial for diagnosis and research.
  • Existing research highlights PPA's impact on language organization and neurodegeneration progression.

Approach:

  • Comprehensive review of current literature on PPA.
  • Analysis of recent advances in neuroanatomy, pathology, and genetics.
  • Examination of biomarker discovery and therapeutic strategies for PPA.

Key Points:

  • PPA exhibits significant heterogeneity in clinical phenotypes.
  • The relationship between PPA's clinical presentations and underlying biology is complex.
  • PPA shares features with other neurodegenerative conditions, including frontotemporal dementia and corticobasal degeneration.

Conclusions:

  • Ongoing research is refining PPA definition, classification, and understanding.
  • Investigating PPA's links to other disorders may clarify disease entities.
  • Future directions focus on biomarkers and effective treatments for PPA.